Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER

EGFR Gene Mutation

Roswell Park Cancer Institutemonoclonal_antibodyPhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

31 Active assets in the EGFR Gene Mutation cohort.

Asset / SponsorPhaseRating
Osimertinib
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 3BB
Gefetinib
China Medical University Hospital
Phase 2/3BB
Carboplatin
Guangdong Provincial People's Hospital
Phase 3B
CIS-DIAMMINEDICHLOROPLATINUM II
Sichuan Cancer Hospital and Research Institute
Phase 3B
Panobinostat
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 3B

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER is also rated in:

malignant pancreatic neoplasmDormant
BBB
Indicative ·
76 / 100
View asset →
adult glioblastomaDormant
BB
Indicative ·
64 / 100
View asset →
pancreatic neoplasmDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →